Czechia· CZ-0235070
REXTOL
A paricalcitol product containing paricalcitol, registered in Czechia by Heaton k.s., Praha. The same ATC class is registered in 12 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Paricalcitol is registered in 12 of 19 countries.
Countries holding a registration under ATC H05BX02 (paricalcitol), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Paricalcitol · ATC H05BX02
12 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paricalcitol costs, country by country.
Normalised to the WHO defined daily dose (2 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paricalcitol · price per daily dose (2 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$11.31
The record
At a glance
SÚKL (Czech Republic)- Active substance
- PARICALCITOL
- Manufacturer
- Heaton k.s., Praha
- Country
- Czechia (CZ)
- ATC code
- H05BX02
- ATC class
- Paricalcitol
- Defined daily dose
- 2 mcg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
285 interactions on record for paricalcitol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paricalcitol · interactions on record
285 records
- 11 severe
- 108 moderate
- 166 info
Most severe, free to view
- SucralfateA02BX02severe
- ErgocalciferolA11CC01severe
- DihydrotachysterolA11CC02severe
- CalcitriolA11CC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Paricalcitol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPARICALCITOL ACCORD 5 MICROGRAMOS/ML SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- FinlandParicalcitol AlternovaAlternova A/S
- SwitzerlandZemplar 10 ug/2ml, InjektionslösungAbbVie AG
- PolandParicalcitol FreseniusFresenius Medical Care Nephrologica Deutschland GmbH
- SwedenParicalcitol Accord 5 mikrogram/ml Injektionsvätska, lösningAccord Healthcare B.V.
- United StatesParicalcitolMARKSANS PHARMA LIMITED
- GermanyParicalcitol AccordAccord Healthcare B.V.
- United KingdomZemplar 10micrograms/2ml solution for injection ampoulesAbbVie Ltd
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Paricalcitol Accord, Zemplar
- Bulgaria · Тевапаривит
- Cyprus · Rextol
- Germany · Paricalcitol Accord, Paricalcitol Hexal
- Denmark · Paricalcitol Pharmathen
- Spain · Paricalcitol Accord, Paricalcitol Accordpharma
- Finland · Paricalcitol Accord, Paricalcitol Alternova
- United Kingdom (Northern Ireland) · Zemplar
- Greece · Aricitol, Panozin
- Croatia · Parkol, Zemplar
- Hungary · Paricalcitol Fresenius, Paricalcitol Onkogen
- Ireland · Paricalcitol Pinewood Laboratories, Zemplar
- Italy · Paracalcitolo Mylan, Paracalcitolo Sandoz
- Luxembourg · Porontazin
- Netherlands · Paricalcitol Accord, Paricalcitol Heaton
- Norway · Paricalcitol Alternova
- Poland · Paricalcitol Fresenius
- Portugal · Paricalcitol Accord, Paricalcitol Altan
- Romania · Paricalcitol, Rextol
- Sweden · Paricalcitol Accord, Paricalcitol Alternova
- Slovenia · Zemplar
- Slovakia · Paricalcitol Heaton, Zemplar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66c3f81c-c343-497a-8e4b-cf9496cdbe5a GET /v1/drugs/66c3f81c-c343-497a-8e4b-cf9496cdbe5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "5MCG/ML",
"pack_size": "1X1ML",
"substance": "PARICALCITOL",
"cz_kod_sukl": "0235070",
"product_type": "CH",
"substance_codes": "15512",
"registration_state": "R",
"registration_number": "56/538/11-C"
}See everything about paricalcitol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.